RYTHM (RYM)
Licenses cannabis brands and sells hemp-derived THC consumer products.
Something off on this page? Send us feedback.
Owns cannabis and hemp brand IP, licensing specified brands to Green Thumb. It also sells hemp-derived THC products under its portfolio of brands.
Owns a portfolio of hemp-derived THC products and cannabis brand intellectual property, including RYTHM, incredibles, Dogwalkers, Beboe, &Shine, Doctor Solomon’s, Good Green, and Señorita. Its consumer-products business includes hemp-derived THC beverages across its branded portfolio.
Licenses specified brands to Green Thumb, which manufactures and distributes them. Green Thumb is also a major shareholder and has board representation, making the relationship central to the operating model. The company exited its legacy cultivation-equipment and extraction businesses before adopting the current IP-owner, licensing, and consumer-products model. The portfolio reflects the issuer's well-being positioning.
Company facts
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $41.9M · Total debt $80.6M · Total assets $135.4M · Shareholders' equity $39.1M
- Revenue
- $23.0M
- Operating income
- $1.9M
- Net income
- $1.2M
No dividends on record.
| Institutions | 7.53% | 164.2K shares | |
|---|---|---|---|
| 16 holders · as of Jun 30, 2026 | |||
| Insiders | 6.83% | 148.8K shares | |
| 10 holders · as of Jun 18, 2026 | |||
| Strategic holders | 42.54% | 927.0K shares | |
| 2 holders · as of Feb 5, 2026 | |||
| Other | 43.10% | 939.2K shares | |
| remainder | |||
2.18M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Rslgh, LLCStrategic10 percent owner | 32.08% | 698,961 | filed May 29, 2025 |
Double Or Nothing LLCStrategic | 10.46% | 227,995 | filed Feb 5, 2026 |
Benjamin KovlerInsiderdirector, officer: Interim CEO | 3.04% | 66,269 | filed Nov 20, 2025 |
Vanguard Capital Management LLCInstitution | 2.07% | 45,191 | as of Jun 30, 2026 |
Ieq Capital, LLCInstitution | 1.60% | 34,897 | as of Jun 30, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Jun 17, 2026 | Armon Vakili | director | −2,250 | $26.52 |
| Jun 16, 2026 | Max Holtzman | director | −5,000 | $26.00 |
| Jun 11, 2026 | Timothy Mahoney | director | −5,000 | $26.34 |
| Sep 25, 2025 | Benjamin Kovler | director, officer: Interim CEO | +1,000 | $37.08 |
| Sep 19, 2025 | Benjamin Kovler | director, officer: Interim CEO | +1,000 | $39.99 |
- Tilray Brands
Cannabis brands and beverage-scale consumer distribution
- Canopy Growth
Branded cannabis and hemp products, including U.S. operations
- Cronos Group
Adult-use cannabis brands with leading edible-product positions
- Organigram Global
Canadian recreational cannabis brands across edibles and vapes
CompareAfter hours
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| RYTHM | $23.84 | +2.67% | $50.0M | — | — | 1.0 | +1,027.4% |
| Tilray Brands | $4.24 | +0.24% | $456.3M | — | — | 0.4 | +25.5% |
| Canopy Growth | $0.9782 | +0.44% | $390.0M | — | — | 1.7 | −20.8% |
| Cronos Group | $3.46 | +1.02% | $1.24B | 18.4 | 57.1 | 5.1 | +58.4% |
| Organigram Global | $1.11 | −0.89% | $157.7M | 2.5 | 37.4 | 0.7 | +43.2% |
| Median | 10.4 | 47.3 | 1.2 | +34.3% |